cover image: Socio-Economic Value of Adult Immunisation Programmes


Socio-Economic Value of Adult Immunisation Programmes

22 Apr 2024

Adult vaccines can return up to 19 times their initial investment to society, when their significant benefits beyond the healthcare system are monetised. This report demonstrates the health and socioeconomic value of adult immunisation programmes against seasonal influenza (influenza), pneumococcal disease (PD), herpes zoster (HZ), and respiratory syncytial virus (RSV) in ten countries (Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, and the United States of America).


Hania El Banhawi, Sulayman Chowdhury, Margherita Neri, Priscila Radu, Sian Besley, Eleanor Bell, Simon Brassel, Lotte Steuten

Published in
United Kingdom


Related Topics